MedPath

To study the utility of oral detrose gel in reducing NICU admission of babies, in the first 2 days of life who develop low sugars and are given intravenous dextrose in the NICU.

Not Applicable
Conditions
Health Condition 1: null- asymptomatic neonates in the first 48 hours of life
Registration Number
CTRI/2017/11/010383
Lead Sponsor
eocore research fund
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Late preterms (born at 34weeks or more as per the LMP/ dating scan)

2. Term at-risk babies :

a. SGA/IUGR (as per fenton growth chart)

b. LGA (as per fenton growth chart)

c.Infant of a diabetic mother

Exclusion Criteria

1.Babies whoâ??re being admitted to NICU for any medical reason.

2.Babies started on intravenous fluids as per physicianâ??s discretion

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare the need for NICU admission and parenteral fluids in the first 48 hours of life in the study group versus the control groupTimepoint: at 48 hours of life, each neonate included in the study will be assessed. <br/ ><br>final assessment in january 2019
Secondary Outcome Measures
NameTimeMethod
to compare the number of babies on exclusive breast feeds at discharge in the study group versus in the control groupTimepoint: Birth to 48 hours of life
© Copyright 2025. All Rights Reserved by MedPath